Abstract
Peptide-based drug development is a rapidly growing field within pharmaceutical research. Nevertheless, peptides have found limited clinical use due to several physiological and pathological factors. Pluronic block copolymers represent a growing technology with the potential to enhance efficacy of peptide therapeutics. This investigation assesses Pluronic P85 (P85) and its potential to enhance opioid peptide analgesia. Two opioid peptides, [d-Pen2,d-Pen5]-enkephalin (DPDPE) and biphalin, were examined as to the benefits of P85 coadministration, above (1.0%) and below (0.01%) the critical micelle concentration, with morphine as a nonpeptide control. P85 was examined in vitro to assess blood-brain barrier uptake in association with P-glycoprotein effect, DPDPE and morphine being P-glycoprotein substrates. P85 coadministration with DPDPE and biphalin showed increased (p < 0.01) analgesia with both 0.01 and 1.0% P85. Morphine showed increased (p < 0.01) analgesia with 0.01% P85 only. This increase in analgesia is due to both an increase in peak effect, as well as a prolongation of effect. P85 increased cellular uptake of 125I-DPDPE and [3H]morphine at 0.01% (p < 0.01) and 1.0% (p < 0.01 and p < 0.05, respectively). Cyclosporin-A coadministration with125I-DPDPE and [3H]morphine increased cellular uptake (p < 0.01 andp < 0.05, respectively). 125I-DPDPE and [3H]morphine coadministered with 0.01% P85 and cyclosporin-A increased cellular uptake compared with control (p < 0.01) and compared with cyclosporin-A coadministration without P85 (p < 0.01 andp < 0.05, respectively). This indicates that, in addition to P-gp inhibition, 0.01% P85 increased125I-DPDPE and [3H]morphine uptake. In our examination, we determined that P85 enhanced the analgesic profile of biphalin, DPDPE, and morphine, both above and below the critical micelle concentration.
Footnotes
-
This research was supported by National Institute on Drug Abuse Grants DA 11271, DA 06037, and NS 465201A1.
-
DOI: 10.1124/jpet.102.039545
- Abbreviations:
- CNS
- central nervous system
- BBB
- blood-brain barrier
- SAABC
- self-assembling amphiphilic block copolymer
- PEO
- poly(ethylene oxide)
- P85
- Pluronic P85
- CMC
- critical micelle concentration
- BBMEC
- bovine brain microvessel endothelial cell
- DPDPE
- [d-Pen2,d-Pen5]-enkephalin
- P-gp
- P-glycoprotein
- MPE
- maximum possible effect
- ANOVA
- analysis of variance
- AUC
- area under the curve
- Received June 4, 2002.
- Accepted July 18, 2002.
- The American Society for Pharmacology and Experimental Therapeutics